Capsule Commentary on Al-Khatib et al., Future Research Prioritization: Implantable Cardioverter Defibrillator Therapy in Older Patients.

PubWeight™: 0.75^‹?›

🔗 View Article (PMID 26224152)

Published in J Gen Intern Med on December 01, 2015

Authors

Nicoletta Riva¹, Christian Borg Xuereb²

Author Affiliations

1: Department of Pathology, Faculty of Medicine and Surgery, University of Malta, Msida, Malta. nico.riva@hotmail.it.
2: Department of Psychology, Faculty for Social Wellbeing, University of Malta, Msida, Malta.

Articles cited by this ↗

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation (2013) 10.07

How to increase value and reduce waste when research priorities are set. Lancet (2014) 9.64

Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials. Circ Cardiovasc Qual Outcomes (2015) 1.18

Comparative effectiveness research in heart failure therapies: women, elderly patients, and patients with kidney disease. Heart Fail Clin (2012) 0.87

Future Research Prioritization: Implantable Cardioverter-Defibrillator Therapy in Older Patients. J Gen Intern Med (2015) 0.87